Cardiac bypass haemostasis: putting blood through the mill, British Journal of Haematology, vol.71, issue.2 ,
DOI : 10.1056/NEJM199505183322003
Bleeding complications associated with cardiopulmonary bypass, Blood, vol.76, pp.1680-97, 1990. ,
Eptacog-alpha (activated) aka human clotting factor VII recombinant and activated, in cardiac surgery with cardiopulmonary by pass: where do we stand in 2006? ITBM-RBM, pp.35-39, 2006. ,
Thrombin generation during cardiopulmonary bypass: the possible role of retransfusion of blood aspirated from the surgical field, Thrombosis Journal, vol.1, issue.1, p.3, 2003. ,
DOI : 10.1186/1477-9560-1-3
Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype, Journal of Thrombosis and Haemostasis, vol.95, issue.3, pp.486-493, 2008. ,
DOI : 10.1111/j.1365-2516.2004.00936.x
Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery, Thrombosis and Haemostasis, vol.103, issue.2, pp.318-328, 2010. ,
DOI : 10.1160/TH09-06-0396
Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery, Thrombosis Research, vol.128, issue.3, pp.277-827, 2011. ,
DOI : 10.1016/j.thromres.2011.02.022
Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding, Journal of Thrombosis and Haemostasis, vol.142, issue.Suppl 1, pp.282-292, 2011. ,
DOI : 10.1111/j.1538-7836.2010.04146.x
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma, Pathophysiology of Haemostasis and Thrombosis, vol.33, issue.1, pp.4-15, 2003. ,
DOI : 10.1159/000071636
Platelet dysfunction after normothermic cardiopulmonary bypass in children: Effect of high-dose aprotinin, Thrombosis and Haemostasis, vol.98, pp.385-391, 2007. ,
DOI : 10.1160/TH06-12-0723
Platelet alpha granule depletion: Findings in patients with prosthetic heart valves and following cardiopulmonary bypass surgery, Thrombosis Research, vol.30, issue.3, pp.257-64, 1983. ,
DOI : 10.1016/0049-3848(83)90079-8
Is it possible and worth to use another anticoagulant than (unfractionated) heparin during cardiopulmonary bypass for cardiac surgery? ITBM-RBM, pp.35-39, 2003. ,
Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery, Thrombosis and Haemostasis, vol.93, pp.1101-1108, 2005. ,
DOI : 10.1160/TH04-12-0799
Point-of-care: testing of hemostasis in cardiac surgery, Thrombosis Journal, vol.1, issue.1, p.1, 2003. ,
DOI : 10.1186/1477-9560-1-1
Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis"., Journal of Clinical Investigation, vol.98, issue.3, pp.863-874, 1996. ,
DOI : 10.1172/JCI118859
Sturk A: Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant, pp.3534-3575, 1997. ,
Effects of plasma dilution on tissue factor-induced thrombin generation and thromboelastography: partly compensating role of platelets, Transfusion, vol.27, issue.11, pp.2384-2394, 2008. ,
DOI : 10.1111/j.1537-2995.2008.01872.x